Clopidogrel clinical trials
Also written Plavix and Plavix 600 mg.
How each study uses Clopidogrel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Clopidogrel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 17 Nov 1997 · PLAVIX · NDA 020839 (FDA, Drugs@FDA)
- European Union
- 14 Jul 1998 · Iscover · EMEA/H/C/000175 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- Zyllt
- 1
Studies by the year they started
336 studies that test it; most in 2009 (32); 2 more planned to start later
| Year | Studies |
|---|---|
| 1999 | 3 |
| 2002 | 4 |
| 2003 | 6 |
| 2004 | 12 |
| 2005 | 7 |
| 2006 | 16 |
| 2007 | 10 |
| 2008 | 27 |
| 2009 | 32 |
| 2010 | 25 |
| 2011 | 16 |
| 2012 | 24 |
| 2013 | 17 |
| 2014 | 12 |
| 2015 | 25 |
| 2016 | 11 |
| 2017 | 13 |
| 2018 | 12 |
| 2019 | 9 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 13 |
| 2023 | 11 |
| 2024 | 3 |
| 2025 | 10 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 71 · Other 268
Sanofi (25) · Kafrelsheikh University (8) · Seoul National University Hospital (7) · Ottawa Heart Institute Research Corporation (7) · University of Maryland, Baltimore (5) · Shenyang Northern Hospital (5) · St. Antonius Hospital (5) · Assistance Publique - Hôpitaux de Paris (4)
Often tested with
Tested in the same studies.
Aspirin (97) · Ticagrelor (52) · Prasugrel (25) · Cilostazol (12) · Rivaroxaban (9) · Atorvastatin (7) · Omeprazole (4) · Rosuvastatin (4)
Related medicines
As reviewed, each with the page that says it.
- One of P2Y12 inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 5 phase 3 studies under way
Clopidogrel is the comparator. A study of two new drugs counts under both.
- 2Ticagrelor · University of Florida, Cardiocentro Ticino · next primary completion Jan 2027
- 2Rivaroxaban · University of Florida, The First Affiliated Hospital with Nanjing Medical University · next primary completion Jan 2027
- 1Aspirin · University of Florida · next primary completion Jan 2027
- 1Sumecigrel · Jiangsu vcare pharmaceutical technology co., LTD · next primary completion Dec 2026
- 1Prasugrel · Cardiocentro Ticino · next primary completion Apr 2028
- 1Dabigatran · University of Zurich
- 1Apixaban · University of Zurich
- 1Edoxaban · University of Zurich
Reaching primary completion within a year · 10, 1 in phase 3
Studies that test Clopidogrel, phase 3 first.
- Mar 2027AERIAL Trial: Antiplatelet Therapy in Heart TransplantationPhase 3 · Ottawa Heart Institute Research Corporation
- Dec 2026NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCIPhase 4 · China National Center for Cardiovascular Diseases
- Dec 2026Clopidogrel Versus Cilostazol on VesselsPhase 4 · Seoul National University Bundang Hospital
- Mar 2027A Pilot Study to Investigate Platelet Reactivity in Patients With Elevated Lipoprotein(a) and Its Response to Antiplatelet TherapyNot applicable · François MACH
- Apr 2027Personalizing Thromboprophylaxis for Patients With Peripheral Artery DiseaseNot applicable · Massachusetts General Hospital
- Jul 2027Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor StrokePhase 4 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Aug 2027Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICADNot applicable · Sunnybrook Health Sciences Centre
- Aug 2027Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)Phase 4 · University of Florida
- Aug 2027Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of ClopidogrelEarly Phase 1 · Washington State University
- Oct 2027Vascular Trial Associated Registry PilotPhase 4 · Corewell Health West
Studies
Open first, then newest update. How each study uses Clopidogrel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 339
- Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME)Not yet recruitingPhase 2University of AlbertaNCT07844603Written as Aspirin + Clopidogrel
- Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus BacteremiaRecruitingPhase 4Todd C. Lee MD MPH FIDSANCT06650488Written as Clopidogrel
- Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)RecruitingPhase 4University of FloridaNCT07025148Written as Clopidogrel
- Personalizing Thromboprophylaxis for Patients With Peripheral Artery DiseaseRecruitingNot applicableMassachusetts General HospitalNCT07613840Written as Clopidogrel
- NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCIRecruitingPhase 4China National Center for Cardiovascular DiseasesNCT05638867Written as Aspirin + Clopidogrel + Rivaroxaban
- A Clinical Trial of Antiplatelets in PsoriasisNot yet recruitingPhase 4NYU Langone HealthNCT07744191Written as Clopidogrel
- A Pilot Study to Investigate Platelet Reactivity in Patients With Elevated Lipoprotein(a) and Its Response to Antiplatelet TherapyNot yet recruitingNot applicableFrançois MACHNCT07720934Written as Clopidogrel
- Vascular Trial Associated Registry PilotRecruitingPhase 4Corewell Health WestNCT07076082Written as Clopidogrel (Plavix) Pharmacogenetic Test Reagents
- Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal RevascularizationRecruitingPhase 3Fondation Hôpital Saint-JosephNCT07512960Written as Clopidogrel 75 mg/day
- Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic StrokeNot yet recruitingPhase 4Sichuan Provincial People's HospitalNCT07644234Written as Clopidogrel
- Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of ClopidogrelRecruitingEarly Phase 1Washington State UniversityNCT06692933Written as Clopidogrel
- Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf CountriesNot yet recruitingPhase 3Khalid F AlhabibNCT07572747Written as Clopidgrel 75 mg daily
- AERIAL Trial: Antiplatelet Therapy in Heart TransplantationRecruitingPhase 3Ottawa Heart Institute Research CorporationNCT04770012Written as Clopidogrel
- Clopidogrel Versus Cilostazol on VesselsRecruitingPhase 4Seoul National University Bundang HospitalNCT06402747Written as Clopidogrel
- Adjuvant Clopidogrel in Staphylococcus Aureus BacteremiaNot yet recruitingPhase 2Fundación Pública Andaluza para la gestión de la Investigación en SevillaNCT07384702Written as Clopidogrel
- A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)RecruitingPhase 3Aarhus University HospitalNCT07012629Written as Clopidogrel
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICADRecruitingNot applicableSunnybrook Health Sciences CentreNCT06714526Written as clopidogrel + aspirin
- Mechanistic Study of Anti-Platelet Therapy in AtherosclerosisNot yet recruitingNot applicableGuy's and St Thomas' NHS Foundation TrustNCT07169513Written as Clopidogrel 75 mg daily
- Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06591338Written as Clopidogrel
- Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBRNot yet recruitingPhase 4Samsung Medical CenterNCT06763744Written as clopidogrel + aspirin
See all 339 studies that test Clopidogrel →
Given beside what is tested · 66 — Clopidogrel is usual care or a partner of the new treatment
- Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial StenosisRecruitingPhase 4Second Affiliated Hospital of Soochow UniversityNCT07932639Written as Clopidogrel
- Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery EctasiaRecruitingPhase 4Instituto Nacional de Cardiologia Ignacio ChavezNCT07511257Written as Clopidogrel 75 mg
- The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery AtherosclerosisRecruitingPhase 4Asan Medical CenterNCT06757764Written as Clopidogrel
- Acetyl-leucine in Post-stroke AtaxiaRecruitingPhase 3Kafrelsheikh UniversityNCT07275749Written as Clopidogrel 75 Mg Oral Tablet
- to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and ApixabanRecruitingPhase 1Onconic Therapeutics Inc.NCT07265466Written as JP-1366 and clopidogrel
- Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary InterventionRecruitingPhase 4Peking Union Medical College HospitalNCT03378934Written as Clopidogrel
- Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic StrokeRecruitingPhase 3Kafrelsheikh UniversityNCT06360120Written as Clopidogrel 75 Mg Oral Tablet
- Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy SubjectsNot yet recruitingPhase 1HK inno.N CorporationNCT06164834Written as Clopidogrel 75 mg
- Efficacy and Safety of PFO Closure vs Medical Therapy in Alleviating MigraineCompletedPhase 3Guangdong Provincial People's HospitalNCT04946734Written as Aspirin and clopidogrel
- Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients TrialCompletedPhase 4The TIMI Study GroupNCT04409834Written as Clopidogrel
- A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy SubjectsCompletedPhase 1Lumosa Therapeutics Co., Ltd.NCT04809818Written as Clopidogrel
- Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm RepairCompletedPhase 2/3Beijing Tiantan HospitalNCT06238115Written as aspirin, clopidogrel
- Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous DiseaseCompletedPhase 2Chang Gung Memorial HospitalNCT04824911Written as Clopidogrel
- Study of the AFB and Stenting of the Iliac ArteriesCompletedPhase 1Meshalkin Research Institute of Pathology of CirculationNCT02209350Written as Therapy: aspirin and clopidogrel
- Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy SubjectsCompletedPhase 1Tianjin Institute of Pharmaceutical Research Co., LtdNCT06584812Written as Clopidogrel
- P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable ScaffoldTerminatedPhase 4Samsung Medical CenterNCT03119012Written as Clopidogrel
- Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery LesionsActive, not recruitingNot applicableXijing HospitalNCT05209412Written as Clopidogrel
- PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 MetabolizersCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT05162053Written as Clopidogrel Tablets
- A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and ClopidogrelCompletedPhase 2Bristol-Myers SquibbNCT03766581Written as Clopidogrel
- To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary SyndromeStatus unknownPhase 4Sarmad ZahoorNCT05573958Written as Clopidogrel tablet
Showing 20 of 66.
As the comparator · 178 — what is tested is compared with Clopidogrel
- Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) TrialNot yet recruitingPhase 4Universitätsklinikum Hamburg-EppendorfNCT07683923Written as ASA plus Clopidogrel
- BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral AtherosclerosisRecruitingPhase 4Yonsei UniversityNCT07237308Written as Clopidogrel
- The Switching Antiplatelet-9 (SWAP-9) StudyRecruitingPhase 4University of FloridaNCT06588595Written as Aspirin plus clopidogrel
- Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery DiseaseNot yet recruitingPhase 4University of MessinaNCT07080684Written as clopidogrel 75 mg
- Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban TherapyRecruitingPhase 4Seoul National University Bundang HospitalNCT07796217Written as Clopidogrel with or without aspirin
- Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)RecruitingPhase 3Jiangsu vcare pharmaceutical technology co., LTDNCT06577519Written as Clopidogrel
- The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy ParticipantsRecruitingPhase 1Shanghai CureGene Pharmaceutical Co., Ltd.NCT07619885Written as Clopidogrel
- Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCIRecruitingPhase 4Medical University of GdanskNCT04695106Written as Clopidogrel
- Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.RecruitingPhase 3Cardiocentro TicinoNCT07582835Written as Clopidogrel
- Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) StudyRecruitingPhase 4University of FloridaNCT06821191Written as clopidogrel 75 mg
- STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral AnticoagulantRecruitingPhase 4Chinese Academy of Medical Sciences, Fuwai HospitalNCT06901466Written as Active Comparator: Rivaroxaban+Clopidogrel
- STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral AnticoagulantRecruitingPhase 4Chinese Academy of Medical Sciences, Fuwai HospitalNCT07007143Written as Active Comparator: Aspirin+Clopidogrel
- Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary InterventionRecruitingPhase 4University of FloridaNCT06228456Written as Clopidogrel
- Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With CilostazolNot yet recruitingPhase 4First Affiliated Hospital of Chengdu Medical CollegeNCT07180472Written as Clopidogrel
- VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb RevascularizationRecruitingPhase 4Science Valley Research InstituteNCT06873321Written as clopidogrel 75 mg od for 3 months followed by aspirin 100 mg od for endovascular procedures or aspirin for open procedures
- Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).RecruitingPhase 2Tianjin Institute of Pharmaceutical Research Co., LtdNCT06601127Written as Clopidogrel
- Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer PhenotypeNot yet recruitingPhase 4The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT06486363Written as Aspirin combined with clopidogrel
- Pharmacodynamic Outcomes in CCS Patients Treated With an Individualized Treatment StrategyRecruitingPhase 4St. Antonius HospitalNCT05773989Written as Clopidogrel
- Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic StenosisNot yet recruitingPhase 2/3The First Affiliated Hospital with Nanjing Medical UniversityNCT05700266Written as Clopidogrel
- Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During HospitalizationRecruitingPhase 4Mikhail ZykovNCT06102720Written as Clopidogrel
Showing 20 of 178.
Codes
What other systems call Clopidogrel · ClinicalTrials.gg INT006648
- MeSH (NLM) D000077144ClopidogrelConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) A74586SNO7CLOPIDOGRELConfirmed FDA, NLM, Wikidata
- RxNorm 32968Confirmed FDA, Wikidata
- Wikidata Q410237clopidogrelConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61686ClopidogrelOne source FDA
- DrugBank DB00758One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077144 | Clopidogrel | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | A74586SNO7 | CLOPIDOGREL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 32968 | — | Confirmed FDA, Wikidata |
| Wikidata | Q410237 | clopidogrel | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61686 | Clopidogrel | One source FDA |
| DrugBank | DB00758 | — | One source Wikidata |
Also registered as clopidogrel besylate (UNII BL9VGG8BHW), clopidogrel bisulfate (UNII 08I79HTP27 · RxNorm 236991) and clopidogrel hydrochloride (UNII 426O7XWS6Y).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.